Azithromycin Actavis
국가: 뉴질랜드
언어: 영어
출처: Medsafe (Medicines Safety Authority)
환자 정보 전단 유효 성분:
Azithromycin monohydrate 511.35mg equivalent to azithromycin 500 mg; ;
제공처:
Actavis New Zealand Limited
INN (국제 이름):
Azithromycin monohydrate 511.35 mg (equivalent to azithromycin 500 mg)
복용량:
500 mg
약제 형태:
Film coated tablet
구성:
Active: Azithromycin monohydrate 511.35mg equivalent to azithromycin 500 mg Excipient: Calcium phosphate Croscarmellose sodium Ethanol Magnesium stearate Opadry White OY-B-28920 AMB Pregelatinised maize starch Purified water Sodium laurilsulfate
패키지 단위:
Blister pack, Al foil/Al foil, 2 tablets
수업:
Prescription
처방전 유형:
Prescription
Manufactured by:
PLIVA Croatia Ltd.
치료 징후:
Azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1. Lower respiratory tract infections: acute bacterial bronchitis due to Streptococcus pneumoniae, Haemophilus influenzae or Moraxella catarrhalis community acquired pneumonia due to Streptococcus pneumoniae or Haemophilus influenzae in patients suitable for outpatient oral treatment. Community acquired pneumonia caused by susceptible organisms in patients who require initial intravenous therapy. In clinical studies efficacy has been demonstrated against Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophilia, Moraxella catarrhalis, Mycoplasma pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae.
제품 요약:
Package - Contents - Shelf Life: Blister pack, Aluminium foil/PVC/PE/PVDC or Aluminium foil/Al foil - 2 tablets - 36 months unopened stored at or below 25°C - Blister pack, Al foil/PVC/PE/PVDC or Aluminium foil/Al foil - 3 tablets - 36 months unopened stored at or below 25°C
승인 날짜:
2004-08-09
환자 정보 전단
ARROW - AZITHROMYCIN
Azithromycin 500 mg tablets
WHAT IS IN THIS LEAFLET
This leaflet answers some common questions about ARROW -
AZITHROMYCIN.
It does not contain all the available information. It does not take the place of
talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of
your taking ARROW - AZITHROMYCIN against the benefits they expect it will
have for you.
IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again.
WHAT ARROW - AZITHROMYCIN IS USED FOR
ARROW - AZITHROMYCIN contains azithromycin monohydrate. It is an
antibiotic that belongs to a group of medicines called azalides, a sub-class of
macrolide antibiotics. Azithromycin works by killing or stopping the growth of
bacteria causing your infection.
ARROW - AZITHROMYCIN are used to treat bacterial infections such as
• respiratory infections eg bronchitis, pneumonia, sinusitis, pharyngitis,
tonsillitis and otitis media
• skin and skin structure infections including abscess and ulcers
• sexually transmitted diseases eg chlamydia or gonorrhoea
• pelvic inflammatory disease (infection and inflammation of uterus,
fallopian tubes and ovaries)
• an uncommon eye infection (_Chlamydia trachomatis_ conjunctivitis and
trachoma).
Like other antibiotics, ARROW - AZITHROMYCIN does not work against viral
infections such as colds or flu.
ARROW - AZITHROMYCIN can be used to prevent infection due to
_Mycobacterium avium-intracellulare_ complex disease in HIV-infected patients.
Your doctor may have prescribed ARROW - AZITHROMYCIN for another
purpose. Ask your doctor if you have any questions about wh
전체 문서 읽기
제품 특성 요약
ARROW - AZITHROMYCIN
Azithromycin (as monohydrate) 500 mg tablets
PRESENTATION
Arrow - Azithromycin is a white to off-white, film-coated, capsule-shaped, biconvex
tablet, with " " on one side and "AT
│500" on the other side. Each tablet contains
500 mg azithromycin (as monohydrate).
USES
_ACTIONS _
Azithromycin is the first of a new class of antibiotics designated chemically as
azalides, a subclass of macrolides, available for oral administration. Azithromycin
acts by binding to the 50S ribosomal subunit of susceptible organisms, thus
interfering with the microbial protein synthesis. Nucleic acid synthesis is not affected.
_PHARMACODYNAMICS _
MICROBIOLOGY
Azithromycin demonstrates activity _in vitro_ against a wide range of bacteria including
the following:
GRAM-POSITIVE AEROBIC BACTERIA
- _Staphylococcus aureus_, _Streptococcus pyogenes_
(group A beta-haemolytic streptococci), _Streptococcus pneumoniae_, alpha-
haemolytic streptococci (viridans group) and other streptococci, and
_Corynebacterium diphtheriae_
. Azithromycin demonstrates cross resistance with
erythromycin resistant-positive strains, including _Streptococcus faecalis_
(enterococcus) and most strains of methicillin-resistant staphylococci.
GRAM-NEGATIVE AEROBIC BACTERIA
- Haemophilus influenzae (including beta-
lactamase producing Haemophilus influenzae), Haemophilus parainfluenzae,
Moraxella catarrhalis, Acinetobacter species, Yersinia species, Legionella
pneumophila, Bordetella pertussis, Bordetella parapertussis, Shigella species,
Pasteurella species, Vibrio cholerae and parahaemolyticus, Plesiomonas
shigelloides. Activities against Escherichia coli, Salmonella enteritidis, Salmonella
typhi, Enterobacter species, Aeromonas hydrophila and Klebsiella species are
variable and susceptibility tests should be performed
전체 문서 읽기
